Share
Trueinvivo exhibited (and attended) the International Conference on Dosimetry and its Applications (ICDA-2) at the University of Surrey from 3rd to 8th July 2016. There was great interest in the micro silica beads and their potential use. The company also made very good international connections and is in the process of signing a Memorandum of Understanding (MOU) with another organisation.
Related Posts
TrueInvivo enhances cancer care with accurate, high-resolution in-vivo dosimetry system, optimizing radiotherapy outcomes.
TRUEinvivo's DOSEmapper™ technology receives enthusiastic feedback from industry leaders at ESTRO37 conference.
USA patent granted for DOSEmapper™ TLD bead strings & Automated Reader.
TRUEinvivo® is pleased to announce that the patent for the DOSEmapper™ TLD bead strings and Automated DOSEmapper™ TLD Reader was granted in the EU on 6th January 2021
